Spots Global Cancer Trial Database for Study of Ixabepilone (BMS-247550) in Patients With Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of Ixabepilone (BMS-247550) in Patients With Solid Tumors
Official Title: Phase I Study of Ixabepilone (BMS-247550) in Patients With Solid Tumors
Study ID: NCT01018966
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to determine the DLT, MTD and recommended Phase II dose of ixabepilone in Japanese patients with solid tumors.
Detailed Description:
Keywords
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
